Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.

Fleroxacin (Ro 23-6240; AM-833) is a new trifluorinated quinolone exhibiting high activity against a broad spectrum of gram-negative and gram-positive bacteria. Healthy male volunteers received, according to a randomized scheme, oral doses of 200, 400, or 800 mg of fleroxacin in tablet form, an intr...

Full description

Saved in:
Bibliographic Details
Main Authors: Weidekamm, E, Portmann, R, Suter, K, Partos, C, Dell, D, Lücker, P W
Format: Artigo
Language:Inglês
Published: 1987
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC175826/
https://ncbi.nlm.nih.gov/pubmed/3125788
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items